Publications:
- Gattazzo C, Teramo A, Passeri F, DeMarch E, Carraro S, Trimarco V, Frezzato F, Berno T, Barila' G, Martini V, Piazza F, Trentin L, Facco M, Semenzato G, Zambello R (2014) Haematologica. 2014 Sep 5. pii: haematol.2014.105726.
- Manni S, Toscani D, Mandato E, Brancalion A, Quotti Tubi L, Macaccaro P, Cabrelle A, Adami F, Zambello R, Gurrieri C, Semenzato G, Giuliani N, Piazza F. Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2 (2014) Leukemia doi: 10.1038/leu.2014.178.
- Quotti Tubi L, Gurrieri C, Brancalion A, Bonaldi L, Bertorelle R, Manni S, Pavan L, Lessi F, Zambello R, Trentin L, Adami F, Ruzzene M, Pinna LA, Semenzato G, Piazza F (2013) Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity. Journal of Hematology & Oncology, 6 (78).
- Manni S, Brancalion A, Mandato E, Quotti Tubi L, Colpo A, Pizzi M, Cappellesso R, Zaffino F, Di Maggio SA, Cabrelle A, Marino F, Zambello R, Trentin L, Adami F, Gurrieri C, Semenzato G, Piazza F (2013) Protein kinase CK2 inhibition down modulates the NF-kB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells. PLOS One, 8(9): e75280. doi: 10.1371/journal.pone.0075280.
- Teramo A, Gattazzo C, Passeri F, Lico A, Tasca G, Cabrelle A, Martini V, Frezzato F, Trimarco V, Ave E, Boscaro E, Piazza F, Facco M, Trentin L, Semenzato G, Zambello R. Blood 2013 121(19): 3843-3854. PMID 23515927.
- Piazza F, Manni S, Semenzato G. Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3. Leukemia Research, 2013 37(2): 221-227. PMID: 23174190.
- Manni S, Brancalion A, Quotti Tubi L, Colpo A, Pavan L, Cabrelle A, Ave E, Zaffino F, Di Maira G, Ruzzene M, Adami F, Zambello R, Pitari MR, Tasson P, Pinna LA, Gurrieri C, Semenzato G, Piazza F. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response. (2012) Clinical Cancer Research, 2012 (7): 1888-1900. PMID: 22351691.
- Piazza F, Manni S, Ruzzene M, Pinna LA, Gurrieri C, Semenzato G. Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways. (2012) Leukemia, (26): 1174-1179. PMID: 22289987.
- Piazza F, Manni, S, Quotti Tubi L, Montini B, Pavan L, Colpo A, Gnoato M, Cabrelle A, Adami F, Zambello R, Trentin L, Gurrieri C, Semenzato G. Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death. BMC cancer, 2010, 10: 526. PMID: 20920357.
- Gurrieri C, Piazza F, Gnoato M, Montini B, Biasutto L, Gattazzo C, Brunetta E, Cabrelle A, Cinetto F, Niero R, Facco M, Garbisa S, Calabrese F, Semenzato G, Agostini C. SB216763 (3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione), a Glycogen Synthase Kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis. J Pharmacol Exp Ther, 332(3):785-794, 2010. PMID: 19959748.
- Piazza FA, Ruzzene M, Gurrieri C, Montini B, Bonanni L, Chioetto G, Di Maira G, Barbon F, Cabrelle A, Zambello R, Adami F, Trentin L, Pinna LA, Semenzato G. (2006) Multiple Myeloma cell survival relies on high activity of protein kinase CK2. Blood, 108(5):1698-707, 2006. PMID: 16684960.
- Agnelli L, Storti P, Todoerti K, Sammarelli G, Dalla Palma B, Bolzoni M, Rocci A, Piazza F, Semenzato G, Palumbo A, Neri A, Giuliani N. Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations. American Journal of Hematology, 2011 (86): E64-E66. PMID: 21953534.
- Piazza F, Manni S, Colpo A, Quotti Tubi L, Semenzato G. Serine-threonine protein kinases CK1, CK2 and GSK-3 in normal and malignant haematopoiesis. Current Signal Transduction Therapy, 2011, 6(1): 88-98.
- Piazza FA, Gurrieri C, Trentin L, Semenzato G. Towards a new age in the treatment of Multiple Myeloma. Ann Hematol, 86(3):159-72, 2007. PMID: 17205287.
- Dell‘Aica I, Niero R, Piazza F, Cabrelle A, Sartor L, Colalto C, Brunetta E, , LoRusso G, Benelli R, Albini A, Calabrese F, Agostini C, Garbisa S. Hyperforin blocks neutrophil activation of MMP-9, motility and recruitment,and restrains inflammation-triggered angiogenesis and lung fibrosis. J Pharmacol Exp Ther, 321(2): 492-500, 2007. PMID: 17289834.
- Scquizzato E, Teramo A, Miorin M, Facco M, Piazza F, Noventa F, Trentin L, Agostini C, Zambello R, Semenzato G. Genotypic evaluation of killer immunoglobulin-like receptors (KIR) in NK-type lymphoproliferative disease of granular lymphocytes. Leukemia, 21: 1060-69, 2007. PMID: 17361229.
- Trentin L, Miorin M, Facco M, Baesso I, Carraro S, Cabrelle A, Maschio N, Bortoli M, Bigotto G, Piazza F, Adami F, Zambello R, Agostini C, Semenzato G. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity. Br J Haematol, 138(5): 594-602, 2007. PMID: 17686053.
- Dall’Aica I, Sartor L, Galletti P, Giacomini D, Quintavalla A, Calabrese F, Giacometti C, Brunetta E, Piazza F, Agostini C, Garbisa S. Inhibition of leukocyte elastase, PMN chemoinvasion, and inflammation-triggered pulmonary fibrosis by a 4-alkyliden-{beta}-lactam with a galloyl moiety. J Pharmacol Exp Ther, 316(2): 539-46, 2006. PMID: 16249367.
- Gurrieri C, Bortoli M, Brunetta E, Piazza F, Agostini C. Cytokines, chemokines and other biomolecular markers in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, 22: S9-S14, 2005. PMID: 16457012.
- Piazza F, Semenzato G. Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction. Expert Rev Anticancer Therapy, 4: 89-102, 2004. PMID: 15161438
Additional publications
- Binotto G, Cillo U, Trentin L, Piazza F, Zaninotto M, Semenzato G, Adami F (2011). Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. Amyloid, 2011, 18 (S1): 132-134. PMID: 21838461
- Piazza F, Costoya JA, Merghoub T, Hobbs R, Pandolfi PP. Disruption of PLZP in mice leads to increased T lymphocytes proliferation and cytokine production and alters the hematopoietic stem cell homeostasis. Mol Cell Biol, 23: 10456-10469, 2004. PMID: 15542853
- Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science, 299: 259-262, 2003. PMID: 12522253
- Merghoub T, Gurrieri C, Piazza F, Pandolfi PP: Modeling Acute Promyelocytic Leukemia in the Mouse: New Insights in the Pathogenesis of Human Leukemias: Blood Cell Mol Dis, 27: 231-248, 2001. PMID: 11358384
- Piazza F, Gurrieri C, Pandolfi PP: The Theory of APL. Oncogene, 20: 7216-7222, 2001. PMID: 11704849
- Trentin L, Agostini C, Facco M, Piazza F, Perin A, Siviero M, Gurrieri C, Galvan S, Adami F, Zambello R, Semenzato G: The chemokine receptor CXCR3 is expresssed on malignant B cells and mediates chemotaxis. J Clin Invest, 104: 115-121, 1999. PMID: 10393705.